We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
851
Structure Therapeutics
GPCR
$3.36B
– –
-18,263
Closed -$880K
GPCR icon
852
PUT
Structure Therapeutics
GPCR
$3.36B
– –
-323
Closed -$42.6K
HUM icon
853
Humana
HUM
$48.3B
– –
-1,667
Closed -$289K
IBIT icon
854
PUT
iShares Bitcoin Trust
IBIT
$61.7B
– –
-122
Closed -$15.6K
IBRX icon
855
PUT
ImmunityBio
IBRX
$8.54B
– –
-270
Closed -$98.6K
INCY icon
856
Incyte
INCY
$25.9B
– –
-19,782
Closed -$1.96M
INO icon
857
Inovio Pharmaceuticals
INO
$143M
– –
-142,164
Closed -$169K
INSW icon
858
International Seaways
INSW
$5.13B
– –
-6,364
Closed -$451K
IOVA icon
859
CALL
Iovance Biotherapeutics
IOVA
$3.95B
– –
-758
Closed -$30K
IOVA icon
860
PUT
Iovance Biotherapeutics
IOVA
$3.95B
– –
-7
Closed -$127
IVVD icon
861
Invivyd
IVVD
$236M
– –
-55,990
Closed -$72.8K
IWM icon
862
PUT
iShares Russell 2000 ETF
IWM
$81.1B
– –
-23
Closed -$196
JANX icon
863
CALL
Janux Therapeutics
JANX
$1.24B
– –
-80
Closed -$19K
KALV
864
DELISTED
KalVista Pharmaceuticals
KALV
– –
-9,001
Closed -$181K
KKR icon
865
CALL
KKR & Co
KKR
$97B
– –
-140
Closed -$50.4K
KPTI icon
866
CALL
Karyopharm Therapeutics
KPTI
$40.8M
– –
-610
Closed -$2.11K
LITE icon
867
Lumentum
LITE
$78.2B
– –
-20,673
Closed -$14.5M
LIVN icon
868
LivaNova
LIVN
$4.52B
– –
-5,004
Closed -$318K
LOB icon
869
Live Oak Bancshares
LOB
$1.84B
– –
-9,595
Closed -$317K
LPCN icon
870
Lipocine
LPCN
$20.3M
– –
-13,442
Closed -$107K
LQDA icon
871
CALL
Liquidia Corp
LQDA
$6.21B
– –
-1,675
Closed -$154K
LQDA icon
872
PUT
Liquidia Corp
LQDA
$6.21B
– –
-126
Closed -$4.18K
LYEL icon
873
PUT
Lyell Immunopharma
LYEL
$353M
– –
-10
Closed -$26.9K
MRK icon
874
PUT
Merck
MRK
$371B
– –
-253
Closed -$12.5K
MTSI icon
875
MACOM Technology Solutions
MTSI
$20.3B
– –
-15,694
Closed -$3.49M
33 34
35
36 37

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.